Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial Of Sunitinib In Advanced Non-Clear Cell Type Renal Cell Carcinoma

NCT01219751 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT01219751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01219751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial Of Sunitinib In Advanced Non-Clear Cell Type Renal Cell Carcinoma
Lead sponsor
Asan Medical Center
Phase
Phase 2
Overall status
Unknown status
Start date
June 30, 2008
Completion date
September 30, 2011
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic renal cell carcinoma